Sunday, February 25, 2018
 
 
New Collaboration with StafaCT Will Optimize Patient Pathways for Cellular Treatments
LAKEWOOD, Colo., Feb. 24, 2018 /PRNewswire/ -- Terumo BCT announced today that it will be the exclusive distributor for Stafa Cellular Therapy (StafaCT), a U.S.-based software developer. StafaCT software supports healthcare facilities and cell labs as they manage each phase of the cel.....
 
Most Adults Fail To Understand That Nicotine Does Not Cause Cancer
BETHESDA, Md., Feb. 24, 2018 /PRNewswire/ -- A new study reveals that most adults hold beliefs about the harms from nicotine that are opposite from what scientists have concluded. The findings, presented at the Society for Research on Nicotine and Tobacco 24th Annual Meeting in Baltimore, .....
 
Chickpea Flour Market to Grow at a CAGR of 4.7% through 2027
As per the report by Future Market Insights (FMI), the global chickpea flour...
 
In MI, a Battle between Veteran Asbestos Cancer Victims and the Asbestos Industry
LANSING, Mich., Feb. 23, 2018 /PRNewswire/ -- Two weeks ago a bill HB 5456 titled Asbestos Claim Transparency, drafted by the National Chamber of Commerce and Asbestos companies was pushed into Michigan with promises of campaign donations, says Goldberg, Persky & White P.C. Today,
 



Immune Checkpoint Inhibitors Market is Anticipated to Cross US$ 25 Billion by 2022
According to the report “Global  
Medical Nutrition Market 2018 to 2023 Comprehensive Analysis | Expected CAGR of 9.2% and Recent Trends
Market Overview:

Wide adoption of cloud solutions especially by enterprises and SMEs to improvise their operations ...
 
Encompass Health declares dividend on common stock
BIRMINGHAM, Ala., Feb. 23, 2018 /PRNewswire/ -- Encompass Health Corporation (NYSE: EHC), formerly known as HealthSouth Corporation, today announced that its board of directors has declared a quarterly cash dividend on its common stock of $0.25 per share, payable on April 1.....
 
US Navy Veterans Mesothelioma Center Now Urges a US Navy Veteran with Mesothelioma to Call Them for Extremely Vital Compensation Tips Including Avoiding Internet Lawyer Nonsense
NEW YORK, Feb. 23, 2018 /PRNewswire/ -- The US Navy Veterans Mesothelioma Center is now urging a US Navy Veteran who has recently been diagnosed with mesothelioma or their family to call them anytime at 800-714-0303 for very honest advice on how not to lose out on their compensation. The group says, "Buying into Internet nons.....
 
Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 2 Clinical Trial Evaluating Defibrotide for the Prevention of Acute Graft-versus-Host Disease
DUBLIN, Feb. 23, 2018 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the first patient has been enrolled in a Phase 2 clinical trial evaluating the efficacy and safety of defibrotide for the prevention of acute Graft-versus-Host-Disease (aGvHD) in adult and pediatric patients after allogen.....
 
Kazia Receives FDA Orphan Designation for GDC-0084
SYDNEY, Feb. 23, 2018 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that the United States Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to Kazia's investigation.....
 
SillaJen Poster Presentation at 2018 GU ASCO Symposium Highlights New Clinical Data in RCC, Intravenous Delivery of Pexa-Vec, Oncolytic Immunotherapy
SAN FRANCISCO and SEOUL, South Korea, Feb. 23, 2018 /PRNewswire/ -- SillaJen, Inc., (KOSDAQ:215600), a clinical-stage, biotherapeutics company focused on the development of oncolytic immunotherapy products for cancer, presented new renal cell carcinoma (RCC) clinical data at the American Socie.....
 
ESSA Pharma Approves Stock Option Plan, RSU Plan, and Option Grants
HOUSTON and VANCOUVER, Feb. 23, 2018 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or the "Company") (TSX-V: EPI, NASDAQ: EPIX), a pre-clinical stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, hereby announces that on Fe.....
 
St. Jude, Life Time To Host 3rd Annual Ride For A Reason Event At Life Time Destinations Nationwide On Saturday, March 3
CHANHASSEN, Minn., Feb. 23, 2018 /PRNewswire/ -- As part of ongoing efforts by St. Jude and Life Time to help kids get healthy, more than 100 Life Time destinations across the country will host the third annual
 


 
 
 
 
 
 
 
 
 
 
 
 
 





About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines